Mice lacking α-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration

被引:94
作者
Drolet, RE
Behrouz, B
Lookingland, KJ
Goudreau, JL [1 ]
机构
[1] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA
[2] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA
[3] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA
关键词
Parkinson's disease; MPTP; alpha-synuclein; dopamine;
D O I
10.1016/j.neuro.2004.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The functional role of a-synuclein in the pathogenesis of Parkinson's disease (PD) is not fully understood. Systemic exposure of alpha-synuclein-deficient mice to neurotoxins provides a direct approach to evaluate how alpha-synuclein may mediate cell death in a common marine model of PD. To this end, wild-type and homozygous alpha-synuclein knock-out mice were treated with sub-chronic and prolonged, chronic exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In the sub-chronic model, wild-type and a-synuclein knock-out mice were treated for five consecutive days with MPTP (1-25 mg/kg, s.c.) or vehicle, and sacrificed 3 days,following the last injection. The prolonged, chronic model consisted of two injections of MPTP (1-20 mg/kg, s.c.) per week for 5 weeks, with co-administration of probenecid (250 mg/kg, i.p.), and animals were sacrificed 3 weeks following the last injection. Sub-chronic administration of MPTP caused a dramatic, dose-dependent decrease in striatal dopamine (DA) concentrations, while an attenuated response was observed in a-synuclein knock-out mice. Similarly, prolonged, chronic administration of MPTP produced a dose-dependent decrease in striatal DA concentrations, and a corresponding loss of striatal vesicular monoamine transporter (VMAT-2) protein in wild-type mice. However mice lacking alpha-synuclein had an attenuated loss of striatal DA concentrations, while no loss of striatal VMAT-2 protein was observed. Both sub-chronic and prolonged, chronic administration of MPTP caused an increase in the 3,4-dihydroxyphenylacetic acid (DOPAC) to DA ratio in wild-type mice, but not in mice lacking a-synuclein. Despite attenuated toxicity, elevated lactate concentrations were observed in alpha-synuclein knock-out mice following prolonged, chronic MPTP administration. The results of this study provide evidence that alpha-synuclein null mice have an attenuated response to the toxic effects of MPTP exposure, even over prolonged periods of time and that the biochemical sequela of a protracted insult to nigrostriatal DA neurons are distinct between mice with and without alpha-synuclein expression. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 39 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   PERMANENT HUMAN PARKINSONISM DUE TO 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) - 7 CASES [J].
BALLARD, PA ;
TETRUD, JW ;
LANGSTON, JW .
NEUROLOGY, 1985, 35 (07) :949-956
[3]   RAPID ATP LOSS CAUSED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN MOUSE-BRAIN [J].
CHAN, P ;
DELANNEY, LE ;
IRWIN, I ;
LANGSTON, JW ;
DIMONTE, D .
JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) :348-351
[4]   Parkinson's disease: Mechanisms and models [J].
Dauer, W ;
Przedborski, S .
NEURON, 2003, 39 (06) :889-909
[5]   Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP [J].
Dauer, W ;
Kholodilov, N ;
Vila, M ;
Trillat, AC ;
Goodchild, R ;
Larsen, KE ;
Staal, R ;
Tieu, K ;
Schmitz, Y ;
Yuan, CA ;
Rocha, M ;
Jackson-Lewis, V ;
Hersch, S ;
Sulzer, D ;
Przedborski, S ;
Burke, R ;
Hen, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14524-14529
[6]   Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats [J].
DeMaria, JE ;
Lerant, AA ;
Freeman, ME .
BRAIN RESEARCH, 1999, 837 (1-2) :236-241
[7]   VARIABILITY AND FUNCTIONAL RECOVERY IN THE N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MODEL OF PARKINSONISM IN MONKEYS [J].
EIDELBERG, E ;
BROOKS, BA ;
MORGAN, WW ;
WALDEN, JG ;
KOKEMOOR, RH .
NEUROSCIENCE, 1986, 18 (04) :817-822
[8]  
Fabre E, 1999, J PHYSIOL BIOCHEM, V55, P325
[9]   Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons [J].
German, DC ;
Liang, CL ;
Manaye, KF ;
Lane, K ;
Sonsalla, PK .
NEUROSCIENCE, 2000, 101 (04) :1063-1069
[10]   A dual effect of 1-methyl-4-phenylpyridinium (MPP(+))-analogs on the respiratory chain of bovine heart mitochondria [J].
Hasegawa, E ;
Kang, D ;
Sakamoto, K ;
Mitsumoto, A ;
Nagano, T ;
Minakami, S ;
Takeshige, K .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 337 (01) :69-74